Whey protein isolate modulates beta-carotene bioaccessibility depending on gastro-intestinal digestion conditions.


Journal

Food chemistry
ISSN: 1873-7072
Titre abrégé: Food Chem
Pays: England
ID NLM: 7702639

Informations de publication

Date de publication:
01 Sep 2019
Historique:
received: 25 05 2018
revised: 25 03 2019
accepted: 01 04 2019
entrez: 23 4 2019
pubmed: 23 4 2019
medline: 6 6 2019
Statut: ppublish

Résumé

Carotenoids are lipophilic phytochemicals; their intake has been associated with reduced chronic diseases. However, their absorption depends on emulsification during digestion and incorporation into mixed micelles, requiring digestive enzymes, gastric peristalsis, bile, and dietary lipids. In this study, we investigated whether whey-protein-isolate (WPI), a commonly consumed protein source, can modulate β-carotene bioaccessibility in vitro, especially under incomplete digestive conditions, i.e. under low digestive enzyme concentrations. Thus, amounts of pepsin, pancreatin, bile, co-digested lipids and kinetic energy and gastric digestion time were modified, and WPI at concentrations equivalent to 0/25/50% of the protein recommended dietary allowance (approx. 60 g/d) were added to β-carotene dissolved in oil. WPI enhanced bioaccessibility by up to 20% (p < 0.001), especially under higher simulated peristalsis or reduced amount of dietary lipids. Conversely, they impaired bioaccessibility to one third (p < 0.001) under incomplete digestive conditions. WPI modulated β-carotene bioaccessibility depending on digestive conditions.

Identifiants

pubmed: 31006454
pii: S0308-8146(19)30651-X
doi: 10.1016/j.foodchem.2019.04.003
pii:
doi:

Substances chimiques

Micelles 0
Whey Proteins 0
beta Carotene 01YAE03M7J
Carotenoids 36-88-4
Pancreatin 8049-47-6
Pepsin A EC 3.4.23.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

157-166

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Mohammed Iddir (M)

Luxembourg Institute of Health, Department of Population Health, Strassen, Luxembourg; Louvain Institute of Biomolecular Science and Technology, UCLouvain, Louvain-la-Neuve, Belgium.

Celal Degerli (C)

Luxembourg Institute of Health, Department of Population Health, Strassen, Luxembourg; Ege University, Engineering Faculty, Food Engineering Department, Izmir, Turkey.

Giulia Dingeo (G)

Luxembourg Institute of Health, Department of Population Health, Strassen, Luxembourg.

Charles Desmarchelier (C)

C2VN, INRA, INSERM, Aix-Marseille Univ, Marseille, France.

Thomas Schleeh (T)

Luxembourg Institute of Science and Technology, Belvaux, Luxembourg.

Patrick Borel (P)

C2VN, INRA, INSERM, Aix-Marseille Univ, Marseille, France.

Yvan Larondelle (Y)

Louvain Institute of Biomolecular Science and Technology, UCLouvain, Louvain-la-Neuve, Belgium.

Torsten Bohn (T)

Luxembourg Institute of Health, Department of Population Health, Strassen, Luxembourg. Electronic address: torsten.bohn@gmx.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH